Alemtuzumab and Natalizumab: The Monoclonal Antibody Story Continues
In the July/August 2006 issue of this journal, the infectious complications associated with the use of infliximab, etanercept and adalimumab were reviewed (1). These represent only three of the many monoclonal antibodies either licensed or in clinical trials for therapeutic use in cancer and autoimm...
| Autores principales: | , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
Hindawi Limited
2006-01-01
|
| Colección: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Acceso en línea: | http://dx.doi.org/10.1155/2006/876252 |